Database parameters
The consensus from the euLITT meeting in September 2024 was that local prospective databases should include the following parameters (at a minimum)
Tumor
Age, Gender, ID-number, Operation date
- Location (frontal, temporal, parietal, occipital, insula, brainstem, posterior fossa, central)
- Tumor indication: Newly-diagnosed glioblastoma / Recurrent glioblastoma / Glioma grade 1 / Glioma grade 2 / Glioma grade 3 / Glioma grade 4 (IDH-mutant) Metastasis / Radiation necrosis / Meningioma / Pediatric brain tumor / Cavernoma / Hemangioma / Other (Text)
- Brain tumor diagnosis date (date of biopsy)
- Initial biopsy result (classification and mutations)
- Biopsy in same session as LITT: Yes (Text) / No
- Complications: Yes (Text) / No
- Recurrence 4-6 weeks post-LITT: Yes / No
- Recurrence 3 months post-LITT: Yes / No
- Recurrence 6 months post-LITT: Yes / No
- Date of recurrence on MRI
- Date of death
Epilepsy
- Age, Gender, ID-number, Operation date
- Location (frontal, temporal,parietal, occipital, insula, central)
- Epilepsy indication: Mesial temporal epilepsy MRI positive / Mesial temporal epilepsy MRI negative / Hypothalamic hamartoma / Dysplasia / Heterotopia / Extratemporal MRI negative / Glioneural tumors (e.g. gangliogliomas, DNET) / Hemangioma / Cavanoma / Corpus callosotomy / Tuberous sclerosis / Other (Text)
- Complications: Yes (Text) / No
- Neurological deficits at 12 months:Yes (Text) / No
- Engel and ILAE outcome at 12 months
- Engel and ILAE outcome at 24 months
